Anadys Pharmaceuticals News
Most Popular Anadys Pharmaceuticals Story
Anadys shares slump despite upbeat hep C data
Anadys Pharmaceuticals started the day by touting preliminary mid-stage data for ANA598 and got some quick support from analysts. But shares of Anadys slumped this morning, proving that it can be Read more...
Latest Headlines
- October 13, 2011
- February 25, 2010
- December 17, 2009
- August 20, 2009
- July 31, 2009
- October 17, 2007
- August 29, 2007
- August 2, 2007
- July 27, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
